Supraventricular Tachyarrhythmias

1 August 1972

journal article
research article
Published by American Medical Association (AMA) in Archives of internal medicine (1960)

Vol. 130 (2) , 221-224
https://doi.org/10.1001/archinte.1972.03650020051009

Abstract

Twelve of 16 (75%) supraventricular tachycardias were abruptly terminated by intravenously administered edrophonium chloride (Tensilon) in doses ranging from 5 to 20 mg. Transient side effects of the drug were seen in five patients (31.3%) and subsided spontaneously as the drug effect was rapidly dissipated. The experience of other investigators is reviewed and the mechanism of drug action is discussed. Despite little recognition to date as an antiarrhythmic agent, edrophonium may prove to be the initial drug treatment of choice in managing a variety of supraventricular tachyarrhythmias.

This publication has 6 references indexed in Scilit:

Fatalities following intravenous use of sodium diphenylhydantoin for cardiac arrhythmias. Report of two cases
JAMA, 1967
Unwanted effects of propranolol
The American Journal of Cardiology, 1966
Use of edrophonium (Tensilon) in the evaluation of supraventricular tachycardias
The American Journal of Cardiology, 1966
Death Following Carotid Sinus Pressure
Published by American Medical Association (AMA) ,1962
SYNTHETIC CURARE‐LIKE AGENTS AND THEIR ANTAGONISTS
Annals of the New York Academy of Sciences, 1951
MONOPLEGIA FOLLOWING CAROTID SINUS PRESSURE IN THE AGED
The Lancet Healthy Longevity, 1947